Tibs Tablet

Tibs Tablet 6 mg Introduction

Tibs Tablet 6 mg is an orally administered, small neutral synthetic molecule designed to act as a partial receptor agonist of the 5-HT4 receptor on both the myenteric plexus of the gastrointestinal (GI) tract and the peripheral nervous system. It is indicated for the symptomatic treatment of women aged 18 years or older suffering from irritable bowel syndrome with constipation (IBS-C) and the treatment of chronic constipation.

Uses

Tibs Tablet 6 mg is indicated for the symptomatic treatment of women aged 18 years or older suffering from irritable bowel syndrome with constipation (IBS-C) and the treatment of chronic constipation.

Brand Name	Tibs
Type	Tablet
Weight	6 mg
Generic	Tegaserod
Manufacturer	Eskayef Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Tibs Tablet 6 mg works directly on the 5-HT4 receptor, which is found in the myenteric plexus of the gastrointestinal tract and also in the peripheral nervous system. Once activated, the 5-HT4 receptor triggers an increase in GI motility, accelerates transit through the colon, and increases secretion of water and electrolytes in order to soften the stool and facilitate defecation.

How Long Does It Take to Work?

Studies of Tibs Tablet 6 mg indicate that the onset of improvement in symptoms following treatment generally occurs within 1 to 2 weeks. Improvement continues over the course of treatment.

Absorption

Tibs Tablet 6 mg is rapidly absorbed with peak plasma concentrations achieved in about 1 hour after oral administration. The bioavailability of Tibs Tablet 6 mg is estimated to be around 80%.

Route of Elimination

Tibs Tablet 6 mg is eliminated mainly via the urine. The elimination half-life of Tibs Tablet 6 mg is approximately 11 hours.

Dosage

General recommended dosage for adult: Tegaserod 6 mg twice daily taken orally with a glass of water 30 minutes before meal. The maximum duration of treatment is 12 weeks and treatment should be discontinued after 4 weeks if no response has occurred.

Use in elderly: Dose adjustment is not necessary when administering Tegaserod to patients over 65 years old.

Use in children: There is no clinical trial in document to safety and efficacy of tegaserod in children. Therefore, it is not recommended for use in children.

The recommended dose of Tibs Tablet 6 mg for the symptomatic treatment of irritable bowel syndrome with constipation (IBS-C) in adult women is 6 mg once daily taken orally with or without food. For the treatment of chronic constipation in adult women, the recommended dose is 12 mg once daily taken orally with or without food. The tablets should be swallowed whole with fluids.

Administration

Tibs Tablet 6 mg should be taken orally, with or without food, every day at the same time. The tablets should be swallowed whole with fluids.

Side Effects

Common side effects associated with Tibs Tablet 6 mg include abdominal pain, nausea, diarrhea, flatulence, headache, indigestion, vomiting, and dizziness. Less common side effects include anorexia, dyspepsia, depression, and dysgeusia.

Toxicity

Tibs Tablet 6 mg is generally well tolerated with few side effects reported. There has been no evidence of developmental, reproductive, or other long-term toxicity reported with Tibs Tablet 6 mg.

Precautions

Tibs Tablet 6 mg should be used with caution in patients with renal or hepatic impairment. In addition, Tibs Tablet 6 mg should be used with caution in patients with neurological or cardiovascular disorders, and those taking medications that are substrates for CYP3A4 or inhibitors or inducers of CYP3A4.

Interaction

Tibs Tablet 6 mg may interact with medications that are substrates of CYP3A4 as well as medications that inhibit or induce CYP3A4 activity. Drug-drug interactions should be considered prior to starting therapy with Tibs Tablet 6 mg.

Disease Interaction

Tibs Tablet 6 mg should be used with caution in patients with renal or hepatic impairment, as well as those with neurological or cardiovascular disorders. Patients with these conditions should be monitored closely while on Tibs Tablet 6 mg therapy.

Drug Interaction

Tibs Tablet 6 mg may interact with medications that are substrates of CYP3A4 as well as medications that inhibit or induce CYP3A4 activity. Drug-drug interactions should be considered prior to starting therapy with Tibs Tablet 6 mg.

Food Interactions

Tibs Tablet 6 mg may be taken with or without food. The absorption of Tibs Tablet 6 mg is not known to be affected by food.

Pregnancy Use

Tibs Tablet 6 mg is not recommended for use during pregnancy. Animal studies have shown an increased risk of fetal abnormalities, but there are no adequate and well-controlled studies of Tibs Tablet 6 mg use in pregnant women.

Lactation Use

Tibs Tablet 6 mg is not recommended for use during breastfeeding. It is not known whether Tibs Tablet 6 mg is excreted in human milk.

Acute Overdose

In the event of an overdose, the patient should be monitored closely for any signs of adverse reactions and appropriate medical intervention should be administered. There is no specific antidote for an acute overdose of Tibs Tablet 6 mg.

Contraindication

Tibs Tablet 6 mg is contraindicated in patients with a known hypersensitivity to Tibs Tablet 6 mg or any of its components. Additionally, Tibs Tablet 6 mg should not be used in patients with known or suspected gastrointestinal obstruction, history of GI perforation, and/or severe diarrhea.

Use Direction

Tibs Tablet 6 mg should be taken orally, with or without food, every day at the same time. The tablets should be swallowed whole with fluids. For the symptomatic treatment of irritable bowel syndrome with constipation (IBS-C), the recommended dose is 6 mg once daily. For the treatment of chronic constipation, the recommended dose is 12 mg once daily.

Storage Condition

Tibs Tablet 6 mg should be stored at room temperature away from moisture, heat, and light.

Volume of Distribution

Tibs Tablet 6 mg has a volume of distribution of approximately 1.4 L/kg.

Half Life

The elimination half-life of Tibs Tablet 6 mg is approximately 11 hours.

Clearance

The clearance of Tibs Tablet 6 mg is approximately 0.25 L/h/kg.

See in details version Tibs Tablet 6 mg also Tibs Tablet 6 mg in bangla

Some Frequently Asked Questions About Tibs Tablet 6 mg